These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31181687)

  • 1. Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art.
    Di Costanzo A; Angelico R
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.
    Bijak M
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review.
    Tajmohammadi A; Razavi BM; Hosseinzadeh H
    Phytother Res; 2018 Oct; 32(10):1933-1949. PubMed ID: 30015401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of silymarin on metabolic syndrome: a review.
    Vahabzadeh M; Amiri N; Karimi G
    J Sci Food Agric; 2018 Oct; 98(13):4816-4823. PubMed ID: 29736939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patented bioavailability enhancement techniques of silymarin.
    Javed S; Kohli K; Ali M
    Recent Pat Drug Deliv Formul; 2010 Jun; 4(2):145-52. PubMed ID: 20156178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
    Kidd P; Head K
    Altern Med Rev; 2005 Sep; 10(3):193-203. PubMed ID: 16164374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to enhance oral bioavailability of Silybum Marianum dry extract: association of mechanochemical activation and spray congealing.
    Passerini N; Perissutti B; Albertini B; Franceschinis E; Lenaz D; Hasa D; Locatelli I; Voinovich D
    Phytomedicine; 2012 Jan; 19(2):160-8. PubMed ID: 21802925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milk thistle in liver diseases: past, present, future.
    Abenavoli L; Capasso R; Milic N; Capasso F
    Phytother Res; 2010 Oct; 24(10):1423-32. PubMed ID: 20564545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessing bioavailability of silymarin.
    Javed S; Kohli K; Ali M
    Altern Med Rev; 2011 Sep; 16(3):239-49. PubMed ID: 21951025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silymarin and Its Role in Chronic Diseases.
    Neha ; Jaggi AS; Singh N
    Adv Exp Med Biol; 2016; 929():25-44. PubMed ID: 27771919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers for oral delivery of silymarin: Improving its absorption and in vivo efficacy in type 2 diabetes and metabolic syndrome model.
    Piazzini V; Micheli L; Luceri C; D'Ambrosio M; Cinci L; Ghelardini C; Bilia AR; Di Cesare Mannelli L; Bergonzi MC
    Int J Pharm; 2019 Dec; 572():118838. PubMed ID: 31715362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of silybin.
    Biedermann D; Vavříková E; Cvak L; Křen V
    Nat Prod Rep; 2014 Sep; 31(9):1138-57. PubMed ID: 24977260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silybin and silymarin--new effects and applications.
    Kren V; Walterová D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):29-41. PubMed ID: 16170386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.
    Abenavoli L; Izzo AA; Milić N; Cicala C; Santini A; Capasso R
    Phytother Res; 2018 Nov; 32(11):2202-2213. PubMed ID: 30080294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damage.
    Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
    Arch Pharm Res; 2011 May; 34(5):767-74. PubMed ID: 21656362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway.
    Martinelli T; Whittaker A; Benedettelli S; Carboni A; Andrzejewska J
    Phytochemistry; 2017 Dec; 144():9-18. PubMed ID: 28863306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review.
    Soleimani V; Delghandi PS; Moallem SA; Karimi G
    Phytother Res; 2019 Jun; 33(6):1627-1638. PubMed ID: 31069872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in the flavonolignan composition of fruits from different Silybum marianum chemotypes and suspension cultures derived therefrom.
    Poppe L; Petersen M
    Phytochemistry; 2016 Nov; 131():68-75. PubMed ID: 27639292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption and metabolism of milk thistle flavanolignans in humans.
    Calani L; Brighenti F; Bruni R; Del Rio D
    Phytomedicine; 2012 Dec; 20(1):40-6. PubMed ID: 23072776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid state mechanochemical activation of Silybum marianum dry extract with betacyclodextrins: Characterization and bioavailability of the coground systems.
    Voinovich D; Perissutti B; Grassi M; Passerini N; Bigotto A
    J Pharm Sci; 2009 Nov; 98(11):4119-29. PubMed ID: 19226635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.